Repository logo

Adaptation of a Commercial NAD+ Quantification Kit to Assay the Base-Exchange Activity and Substrate Preferences of SARM1.

Published version

Repository DOI

Change log


Amici, Adolfo 
Gilley, Jonathan 
Coleman, Michael P 
Orsomando, Giuseppe  ORCID logo


Here, we report an adapted protocol using the Promega NAD/NADH-Glo™ Assay kit. The assay normally allows quantification of trace amounts of both oxidized and reduced forms of nicotinamide adenine dinucleotide (NAD) by enzymatic cycling, but we now show that the NAD analog 3-acetylpyridine adenine dinucleotide (AcPyrAD) also acts as a substrate for this enzyme-cycling assay. In fact, AcPyrAD generates amplification signals of a larger amplitude than those obtained with NAD. We exploited this finding to devise and validate a novel method for assaying the base-exchange activity of SARM1 in reactions containing NAD and an excess of the free base 3-acetylpyridine (AcPyr), where the product is AcPyrAD. We then used this assay to study competition between AcPyr and other free bases to rank the preference of SARM1 for different base-exchange substrates, identifying isoquinoline as a highly effect substrate that completely outcompetes even AcPyr. This has significant advantages over traditional HPLC methods for assaying SARM1 base exchange as it is rapid, sensitive, cost-effective, and easily scalable. This could represent a useful tool given current interest in the role of SARM1 base exchange in programmed axon death and related human disorders. It may also be applicable to other multifunctional NAD glycohydrolases (EC that possess similar base-exchange activity.


Peer reviewed: True

Publication status: Published


NAD(P)ase, NAD/NADH-Glo™ Assay, SARM1, acetylpyridine, acetylpyridine adenine dinucleotide, base exchange, enzyme assay, isoquinoline, pyridine bases, pyridine dinucleotides, Humans, NAD, Chromatography, High Pressure Liquid, Cytoskeletal Proteins, Armadillo Domain Proteins

Journal Title


Conference Name

Journal ISSN


Volume Title



Wellcome Trust (210904/Z/18/Z)
Wellcome Trust (220906/Z/20/Z)